Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune-Related lncRNA Risk Signatures Predict Survival of IDH Wild-Type and MGMT Promoter Unmethylated Glioblastoma.

BioMed research international - 1 Jan 2020

Li Xiaozhi, Meng Yutong

Abstract excerpt

INTRODUCTION: Glioblastoma is the most malignant grade of glioma, and it is also the most common primary tumor in the brain. Immunotherapy is a kind of precise tumor treatment. However, there are limited studies about immune-related lncRNA. This study is aimed at analyzing immune-related lncRNAs in glioblastoma and screening out prognostic factors, providing new potential targets for glioblastoma immunology...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Modification Methylases
Share to DNA Repair Enzymes
Share to Glioblastoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Peroxisome Proliferator-Activated Receptors

Share to RNA, Long Noncoding

Share to Transcriptome

Share to Tumor Suppressor Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 32851059
DOI: 10.1155/2020/1971284
PMCID: PMC7441444

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune-Related lncRNA Risk Signatures Predict Survival of IDH Wild-Type and MGMT Promoter Unmethylated Glioblastoma.PMID 32851059Read ↗

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for GlioblastomaSemantic proximity Read ↗

A Five Immune-Related lncRNA Signature as a Prognostic Target for GlioblastomaSemantic proximity Read ↗

Molecular and clinicopathological characterization of a prognostic immune gene signature associated with MGMT methylation in glioblastomaSemantic proximity Read ↗

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma PrognosisSemantic proximity Read ↗

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma MultiformeSemantic proximity Read ↗

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade GliomasSemantic proximity Read ↗

Molecular subtyping of glioblastoma based on immune-related genes for prognosisSemantic proximity Read ↗

Bioinformatic profiling identifies an immune-related risk signature for glioblastomaSemantic proximity Read ↗

Investigation of Candidate Genes and Mechanism Associated with Immune Cell during the Progression of Glioblastoma based on BioinformaticsSemantic proximity Read ↗

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosisSemantic proximity Read ↗

Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiformeSemantic proximity Read ↗

The immune regulation of BCL3 in glioblastoma with mutated IDH1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.